stoxline Quote Chart Rank Option Currency Glossary
XBiotech Inc. (XBIT)
3.98  0.06 (1.53%)    12-01 16:00
Open: 3.99
High: 3.99
Volume: 20,993
Pre. Close: 3.92
Low: 3.75
Market Cap: 121(M)
Technical analysis
2023-12-01 4:23:38 PM
Short term     
Mid term     
Targets 6-month :  5.18 1-year :  6.05
Resists First :  4.44 Second :  5.18
Pivot price 3.76
Supports First :  3.86 Second :  3.5
MAs MA(5) :  3.81 MA(20) :  3.82
MA(100) :  4.49 MA(250) :  4.23
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  65.2 D(3) :  47.8
RSI RSI(14): 55
52-week High :  6.69 Low :  3
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ XBIT ] has closed below upper band by 9.0%. Bollinger Bands are 33.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 3.99 - 4.01 4.01 - 4.03
Low: 3.71 - 3.73 3.73 - 3.75
Close: 3.95 - 3.98 3.98 - 4.01
Company Description

XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation, and True Human COVID-19 therapy for treating the COVID-19 mutant virus. The company was incorporated in 2005 and is headquartered in Austin, Texas.

Headline News

Sat, 11 Nov 2023
XBiotech (NASDAQ:XBIT) Coverage Initiated by Analysts at ... - Defense World

Sat, 16 Sep 2023
Individual investors account for 50% of XBiotech Inc.'s (NASDAQ ... - Yahoo Finance

Wed, 23 Aug 2023
Biotechs are Accelerating Drug Discovery by Repurposing Platforms ... - Nasdaq

Wed, 11 May 2022
Understanding Small Cap Stocks | Financial Literacy - Investment U

Wed, 02 Feb 2022
J&J to record $610 mln charge related to skin disease drug - Reuters

Wed, 28 Oct 2020
5 Ben Graham Lost Formula Stocks With High Financial Strength - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Shares Out 0 (M)
Shares Float 30 (M)
Held by Insiders 1.98e+007 (%)
Held by Institutions 35.1 (%)
Shares Short 277 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS -3.533e+007
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin -12 %
Return on Assets (ttm) 361.6 %
Return on Equity (ttm) -9.7 %
Qtrly Rev. Growth 300000 %
Gross Profit (p.s.) 0
Sales Per Share -7.12
EBITDA (p.s.) 2.41727e+006
Qtrly Earnings Growth -0.8 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow -18 (M)
Stock Valuations
PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales -0.56
Price to Cash Flow 0.75
Stock Dividends
Dividend 0
Forward Dividend 294470
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android